Cancer chemotherapy and pharmacology represent critical fronts in cancer research, aiming to enhance treatment efficacy while mitigating side effects. Chemotherapy drugs target rapidly dividing cancer cells, disrupting their growth and proliferation. However, these drugs can also affect healthy cells, leading to adverse reactions like nausea, hair loss, and immune suppression. Advancements in pharmacology focus on developing targeted therapies, such as immunotherapy and molecularly targeted agents, which selectively attack cancer cells while sparing healthy tissue. Additionally, research explores novel drug delivery systems to improve drug distribution and minimize toxicity. Understanding the intricate mechanisms of cancer cell biology and drug interactions is paramount for refining chemotherapy regimens and designing more personalized treatment approaches, ultimately striving for better outcomes and improved quality of life for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States